GSK PLC (GSK)
36.97
+0.09
(+0.24%)
USD |
NYSE |
Nov 04, 16:00
36.98
+0.01
(+0.03%)
After-Hours: 20:00
GSK Market Cap: 75.45B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 75.24B |
| October 31, 2024 | 75.00B |
| October 30, 2024 | 75.51B |
| October 29, 2024 | 77.88B |
| October 28, 2024 | 77.28B |
| October 25, 2024 | 76.55B |
| October 24, 2024 | 77.00B |
| October 23, 2024 | 77.49B |
| October 22, 2024 | 77.53B |
| October 21, 2024 | 77.86B |
| October 18, 2024 | 78.65B |
| October 17, 2024 | 79.49B |
| October 16, 2024 | 80.00B |
| October 15, 2024 | 79.49B |
| October 14, 2024 | 79.83B |
| October 11, 2024 | 79.22B |
| October 10, 2024 | 80.00B |
| October 09, 2024 | 82.10B |
| October 08, 2024 | 77.57B |
| October 07, 2024 | 78.81B |
| October 04, 2024 | 79.20B |
| October 03, 2024 | 78.28B |
| October 02, 2024 | 80.49B |
| October 01, 2024 | 82.22B |
| September 30, 2024 | 83.41B |
| Date | Value |
|---|---|
| September 27, 2024 | 83.03B |
| September 26, 2024 | 83.41B |
| September 25, 2024 | 82.72B |
| September 24, 2024 | 83.58B |
| September 23, 2024 | 83.33B |
| September 20, 2024 | 83.21B |
| September 19, 2024 | 84.88B |
| September 18, 2024 | 86.54B |
| September 17, 2024 | 86.80B |
| September 16, 2024 | 88.82B |
| September 13, 2024 | 87.72B |
| September 12, 2024 | 87.92B |
| September 11, 2024 | 89.27B |
| September 10, 2024 | 89.94B |
| September 09, 2024 | 89.61B |
| September 06, 2024 | 89.06B |
| September 05, 2024 | 87.96B |
| September 04, 2024 | 90.27B |
| September 03, 2024 | 88.60B |
| August 30, 2024 | 89.55B |
| August 29, 2024 | 89.21B |
| August 28, 2024 | 89.53B |
| August 27, 2024 | 90.04B |
| August 26, 2024 | 86.76B |
| August 23, 2024 | 86.94B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
58.29B
Minimum
Sep 27 2022
97.31B
Maximum
Jan 17 2020
80.06B
Average
80.09B
Median
Market Cap Benchmarks
| AstraZeneca PLC | 221.47B |
| Pfizer Inc | 157.34B |
| Adaptimmune Therapeutics PLC | 210.89M |
| TC BioPharm (Holdings) PLC | 0.6923M |
| Moderna Inc | 20.59B |
Market Cap Related Metrics
| PE Ratio | 24.04 |
| PS Ratio | 1.920 |
| Price to Book Value | 4.025 |
| Price to Free Cash Flow | 12.60 |
| Price | 36.97 |
| Earnings Yield | 4.16% |
| Operating PE Ratio | 13.45 |
| Normalized PE Ratio | 20.51 |